Dr. Klepin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
S Hawthorne Rd
Winston Salem, NC 27157Phone+1 336-716-2255
Education & Training
- Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
- Wake Forest University Baptist Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 2001 - 2002
- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1998 - 2001
- Medical University of South CarolinaClass of 1998
Certifications & Licensure
- NC State Medical License 1998 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Geriatric Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2007 Jun 01
- Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy Start of enrollment: 2007 Jul 01
- Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance).Catherine Lai, Minji Lee, Olivia Bobek, Jennifer Le-Rademacher, Sumithra Mandrekar
Blood Advances. 2025-01-28 - Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid leukemia and their caregivers: UR-GOAL 3.Kah Poh Loh, Qiao Ming Rachel Ng, Supriya G Mohile, Sally Norton, Ronald M Epstein
Journal of Geriatric Oncology. 2025-01-18 - Oncology Provider and Patient Perspectives on a Cardiovascular Health Assessment Tool utilized during Post-treatment Survivorship Care in Community Oncology (Results f...Chandylen L Nightingale, Emily V Dressler, Maura Kepper, Heidi D Klepin, Simon C Lee
Journal of Medical Internet Research. 2025-01-18
Journal Articles
- Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast CancerAminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society
Abstracts/Posters
- Alliance A041701 - a Randomized Phase 2/3 Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia (AML) Receiving Int...Heidi D. Klepin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Aging and Hematologic Disorders: Exploring the Evidence61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Friday Scientific Workshop on Hematology and Aging: From Bleeding Disorders to Malignant Hematology61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Hypertension and use of bevacizumab among patients treated in community settings.2019 ASCO Annual Meeting - 6/1/2019
- Join now to see all
Other
- Pretreatment evaluation and prognosis of acute myeloid leukemia in older adultsKlepin HD, Larson RA
http://www.uptodate.com/contents/pretreatment-evaluation-and-prognosis-of-acute-myeloid-leukemia-in-
UpToDate, Wolters Kluwer Health - 2012-11-13
Press Mentions
- First-Line Cyramza in NSCLC Gets Split Decision from FDA PanelFebruary 27th, 2020
- FDA Panel Split on PARP Inhibitor for Pancreatic CancerDecember 17th, 2019
- ODAC Cautiously Backs Keytruda in Early Bladder CancerDecember 17th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: